An Analytical Reference Standard
Related Products
Research Tool(s)
28411Bretazenil
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Bretazenil

Item No. 37274

Synonyms
Synonyms
  • Ro 16-6028
Technical Information
Formal Name
8-bromo-11,12,13,13aS-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid, 1,1-dimethylethyl ester
CAS Number
84379-13-5
Molecular Formula
C19H20BrN3O3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/mlEthanol: 20 mg/mlPBS (pH 7.2): Partially soluble
λmax
217 nm
SMILES
CC(C)(C)OC(C1=C2N(C=N1)C3=CC=CC(Br)=C3C(N4[C@@]2([H])CCC4)=O)=O
InChi Code
InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1
InChi Key
LWUDDYHYYNNIQI-ZDUSSCGKSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    Bretazenil (Item No. 37274) is an analytical reference standard categorized as a GABAA receptor positive allosteric modulator.1 Bretazenil has anxiolytic-like effects in mice.2 It induces self-administration in rhesus monkeys but has a lower physical dependence liability in mice compared with benzodiazepines.3,4 This product is intended for analytical forensic applications. This product is also available as a general research tool (Item No. 28411).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Puia, G., Dučič, I., Vicini, S., et alMolecular mechanisms of the partial allosteric modulatory effects of bretazenil at γ-aminobutyric acid type A receptor. Proc. Natl. Acad. Sci. USA 89(8), 3620-3624 (1992).

    2. Cole, J.C., and Rodgers, R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav. Pharmacol. 4(6), 573-580 (1993).

    3. Licata, S.C., and Rowlett, J.K. Self-administration of bretazenil under progressive-ratio schedules: Behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines. Drug Alcohol Depend. 113(2-3), 157-164 (2011).

    4. Mirza, N.R., and Nielsen, E.Ø. Do subtype-selective γ-aminobutyric acidA receptor modulators have a reduced propensity to induce physical dependence in mice? J. Pharmacol. Exp. Ther. 316(3), 1378-1385 (2006).